Radiopharmaceutical/Nuclear Medicine Market Size

Global Radiopharmaceutical/Nuclear Medicine Market Report By Type (Diagnostic Nuclear Medicine And Therapeutic Nuclear Medicine), By Application (Diagnostic Application And Therapeutic Application) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2019-2026

ID:VMR11210229

January 2020

Report Formats:

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Description
Table Of Content

As per this study, the Global Radiopharmaceutical/Nuclear Medicine Market was valued USD X.XX BN (by revenue) in 2019 and is anticipated to reach USD X.XX BN by 2026 with a CAGR of X%.

Radiopharmaceutical/nuclear medicine refers to a radioactive drug used for monitoring and treating patients suffering from cancer, heart related problems, and neural issues. The trace amount of radioisotope present in the medicine binds the organic compound, which is later conveyed, to the target cell, tissue or organ. The rays emitted by radioisotope are detected by specific imaging device. The gamma rays are used for diagnostic purpose whereas short-range alpha or beta rays are used for treatment purpose.

Market Dynamics

Rising commonness of cancer and cardiovascular diseases has led the demand for nuclear medicine. Increasing spending on healthcare followed by rising awareness regarding the medicine is also contributing the market growth. Owing to non-invasive treatment, radiopharmaceutical/nuclear medicine is gaining major traction. However, short-term time of nuclear medicine is likely to hinder the market growth.

This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of radiopharmaceutical/nuclear medicine.

Market Segmentation

The broad radiopharmaceutical/nuclear medicine market has been sub-grouped into type, and application. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.

By Type

Diagnostic Nuclear Medicine
- SPECT Radiopharmaceuticals
- PETRadiopharmaceuticals
Therapeutic Nuclear Medicine
- Alpha Emitters
- Beta Emitters
- Brachytherapy Isotopes

By Application

Diagnostic Application
- SPECT Application
  - Cardiology
  - Lymphoma
  - Neurology
  - Thyroid
  - Other
- PET Application
  - Oncology
  - Cardiology
  - Neurology
  - Other
Therapeutic Application
- Thyroid
- Bone Metastasis
- Lymphoma
- Endocrine Tumor
- Other Therapeutic Application

Regional Analysis

Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for radiopharmaceutical/nuclear medicine in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.

Europe Radiopharmaceutical/Nuclear Medicine Market By Revenue (USD MN)

The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the radiopharmaceutical/nuclear medicine market include Advanced Accelerator Applications, Bayer, Bracco Imaging, Cardinal Health, Curium, Eczacibasi-Monrol Nuclear Products, GE Healthcare, Lantheus Medical Imaging and Nordion among others. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.

METHODOLOGY:

A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY
       2.1. Highlights of Radiopharmaceutical/Nuclear Medicine Market
       2.2. Global Radiopharmaceutical/Nuclear Medicine Market Snapshot

3 . RADIOPHARMACEUTICAL/NUCLEAR MEDICINE – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Radiopharmaceutical/Nuclear Medicine Market
       3.3. Market Restraints of Radiopharmaceutical/Nuclear Medicine Market
       3.4. Opportunities of Radiopharmaceutical/Nuclear Medicine Market
       3.5. Trends of Radiopharmaceutical/Nuclear Medicine Market
       3.6. Porter’s Five Force Analysis of Radiopharmaceutical/Nuclear Medicine Market
       3.7. Radiopharmaceutical/Nuclear Medicine Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Type
           3.7.2 Market Attractive Analysis by Application
           3.7.3 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS
       4.1. Radiopharmaceutical/Nuclear Medicine Value Chain Analysis
       4.2. Radiopharmaceutical/Nuclear Medicine Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Radiopharmaceutical/Nuclear Medicine Raw Material Manufactures List
           4.2.3. Price Trend of Radiopharmaceutical/Nuclear Medicine Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend

5 . GLOBAL RADIOPHARMACEUTICAL/NUCLEAR MEDICINE MARKET ANALYSIS BY TYPE
       5.1 Overview by Type
       5.2 Global Radiopharmaceutical/Nuclear Medicine Market Analysis by Type
       5.3 Market Analysis of Diagnostic Nuclear Medicine by Regions
       5.4 Market Analysis of Therapeutic Nuclear Medicine by Regions

6 . GLOBAL RADIOPHARMACEUTICAL/NUCLEAR MEDICINE MARKET ANALYSIS BY APPLICATION
       6.1 Overview by Application
       6.2 Global Radiopharmaceutical/Nuclear Medicine Market Analysis by Application
       6.3 Market Analysis of Diagnostic Application by Regions
       6.4 Market Analysis of Therapeutic Application by Regions

7 . GLOBAL RADIOPHARMACEUTICAL/NUCLEAR MEDICINE MARKET ANALYSIS BY GEOGRAPHY
       7.1. Regional Outlook
       7.2. Introduction
       7.3. North America
           7.3.1. Overview
           7.3.2. North America Radiopharmaceutical/Nuclear Medicine Market Estimate by Market Segment
           7.3.3. North America Radiopharmaceutical/Nuclear Medicine Market Estimate by Country
           7.3.4. United State
           7.3.5. Rest of North America
       7.4. Europe
           7.4.1. Overview
           7.4.2. Europe Radiopharmaceutical/Nuclear Medicine Market Estimate by Market Segment
           7.4.3. Europe Radiopharmaceutical/Nuclear Medicine Market Estimate by Country
           7.4.4. United Kingdom
           7.4.5. France
           7.4.6. Germany
           7.4.7 Rest of Europe
       7.5. Asia Pacific
           7.5.1. Overview
           7.5.2. Asia Pacific Radiopharmaceutical/Nuclear Medicine Market Estimate by Market Segment
           7.5.3. Asia Pacific Radiopharmaceutical/Nuclear Medicine Market Estimate by Country
           7.5.4. China
           7.5.5. Japan
           7.5.6. India
           7.5.7. Rest of Asia Pacific
       7.6. Latin America
          7.6.1. Overview
           7.6.2. Latin America Radiopharmaceutical/Nuclear Medicine Market Estimate by Market Segment
           7.6.3. Latin America Radiopharmaceutical/Nuclear Medicine Market Estimate by Country
           7.6.4. Brazil
           7.6.5. Rest of Latin America
       7.7. Middle East & Africa
           7.7.1. Overview
           7.7.2. Middle East & Africa Radiopharmaceutical/Nuclear Medicine Market Estimate by Market Segment
           7.7.3. Middle East & Africa Radiopharmaceutical/Nuclear Medicine Market Estimate by Country
           7.7.4. Middle East
           7.7.5. Africa

8 . COMPETITIVE LANDSCAPE OF THE RADIOPHARMACEUTICAL/NUCLEAR MEDICINE COMPANIES
       8.1. Radiopharmaceutical/Nuclear Medicine Market Competition
       8.2. Partnership/Collaboration/Agreement
       8.3. Merger And Acquisitions
       8.4. New Product Launch
       8.5. Other Developments

9 . COMPANY PROFILES OF RADIOPHARMACEUTICAL/NUCLEAR MEDICINE INDUSTRY
       9.1. Company Share Analysis
       9.2. Market Concentration Rate
       9.3. Advanced Accelerator Applications
           9.3.1. Company Overview
           9.3.2. Financials
           9.3.3. Products
           9.3.4. Recent Developments
       9.4. Bayer
           9.4.1. Company Overview
           9.4.2. Financials
           9.4.3. Products
           9.4.4. Recent Developments
       9.5. Bracco Imaging
           9.5.1. Company Overview
           9.5.2. Financials
           9.5.3. Products
           9.5.4. Recent Developments
       9.6. Cardinal Health
           9.6.1. Company Overview
           9.6.2. Financials
           9.6.3. Products
           9.6.4. Recent Developments
       9.7. Curium
           9.7.1. Company Overview
           9.7.2. Financials
           9.7.3. Products
           9.7.4. Recent Developments
       9.8. Eczacibasi-Monrol Nuclear Products
           9.8.1. Company Overview
           9.8.2. Financials
           9.8.3. Products
           9.8.4. Recent Developments
       9.9. Ge Healthcare
           9.9.1. Company Overview
           9.9.2. Financials
           9.9.3. Products
           9.9.4. Recent Developments
       9.10. Lantheus Medical Imaging
           9.10.1. Company Overview
           9.10.2. Financials
           9.10.3. Products
           9.10.4. Recent Developments
       9.11. Nordion
           9.11.1. Company Overview
           9.11.2. Financials
           9.11.3. Products
           9.11.4. Recent Developments

10. IMPACT ANALYSIS OF COVID-19 OUTBREAK
10.1. Impact Analysis of Covid-19 Outbreak on the Market
10.1.1. Direct Impact on Production
10.1.2. Supply Chain and Market Disruption
10.1.3. Financial Impact on Firms and Financial Markets
10.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
10.3. Pre V/S Post COVID-19 Market
10.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Market Size in 2020, by Scenario
10.5. COVID-19: Micro and Macro Factor Analysis on the Market

*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

LIST OF FIGURES

Research Scope of Radiopharmaceutical/Nuclear Medicine Report
Market Research Process
Market Research Methodology
Global Radiopharmaceutical/Nuclear Medicine Market Size, by Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis by Type
Market Attractiveness Analysis by Application
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Radiopharmaceutical/Nuclear Medicine Market Analysis by Type (USD MN)
Global Radiopharmaceutical/Nuclear Medicine Market Analysis in Diagnostic Nuclear Medicine by Geography (USD MN)
Global Radiopharmaceutical/Nuclear Medicine Market Analysis in Therapeutic Nuclear Medicine by Geography (USD MN)
Global Radiopharmaceutical/Nuclear Medicine Market Analysis by Application (USD MN)
Global Radiopharmaceutical/Nuclear Medicine Market Analysis in Diagnostic Application by Geography (USD MN)
Global Radiopharmaceutical/Nuclear Medicine Market Analysis in Therapeutic Application by Geography (USD MN)
Latin America Radiopharmaceutical/Nuclear Medicine Market by Revenue
Middle East & Africa Radiopharmaceutical/Nuclear Medicine Market by Revenue
Recent Development in Radiopharmaceutical/Nuclear Medicine Industry
Company Market Share Analysis, 2019

* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Objectives of Study

Define and measure the global market
Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
Analyze and identify major market trends along with the factors driving or inhibiting the market growth
Study the company profiles of the major market players with their market share
Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

Buy sections of this report
Buy country level reports
Request for historical data
Request discounts available for Start-Ups & Universities

Request for Special Pricing

Why Choose Us

Client First Policy

Excellent Quality

Robust After Sales Support

24/7 Email Support

Clients

Testimonials

" Doing business with Value Market Research was – quick, easy and accurate. We got what we expected. The team was very helpful and processes were altered for our convenience. The whole process from understanding our niche requirements to delivery to after sales was excellent. "

Vincenzo Baydar – Head Planning, Leading Food Chain, US

" Excellent work!! Working with you has been easy and direct. Your flexibility to alter the report scope and timely delivery assisted me in delivering my project proposal on time. "

Mia Tang, Director - Business Strategy, Steel Industry, Germany

" This is our second purchase and we have been obliged by the service. We appreciate the efforts put by Value Market Research in terms of understanding our needs, expanding the scope of the study, delivery and handling after sales queries. "

Global Radiopharmaceutical/Nuclear Medicine Market Report By Type (Diagnostic Nuclear Medicine And Therapeutic Nuclear Medicine), By Application (Diagnostic Application And Therapeutic Application) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2019-2026

ID:VMR11210229

January 2020

Report Formats:

Choose your Buying Option

Choose your Buying Option

Objectives of Study

Buy Chapters or Sections

Why Choose Us

Client First Policy

Excellent Quality

Robust After Sales Support

24/7 Email Support

Clients

Testimonials

Vincenzo Baydar – Head Planning, Leading Food Chain, US

Mia Tang, Director - Business Strategy, Steel Industry, Germany

Jo Chin, Owner of a Manufacturing Plant in Taiwan

Key questions answered by the report

Need specific market information?

Global Radiopharmaceutical/Nuclear Medicine Market Report By Type (Diagnostic Nuclear Medicine And Therapeutic Nuclear Medicine), By Application (Diagnostic Application And Therapeutic Application) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2019-2026

ID:VMR11210229

January 2020

Report Formats:

Choose your Buying Option

Choose your Buying Option

Objectives of Study

Buy Chapters or Sections

Why Choose Us

Client First Policy

Excellent Quality

Robust After Sales Support

24/7 Email Support

Clients

Testimonials

Vincenzo Baydar – Head Planning, Leading Food Chain, US

Mia Tang, Director - Business Strategy, Steel Industry, Germany

Jo Chin, Owner of a Manufacturing Plant in Taiwan

Key questions answered by the report

Need specific market information?

Important: Covid19 pandemic market impact